Workflow
Vantage Corp-A(VNTG)
icon
Search documents
Vantage Corp Affirms Strong Business Fundamentals and Stable Core Operations Amid Recent Share Price Volatility
Businesswire· 2025-10-10 12:30
Oct 10, 2025 8:30 AM Eastern Daylight Time SINGAPORE--(BUSINESS WIRE)--Vantage Corp (NYSE American: VNTG) ("Vantage†or the Vantage Corp CEO Andre D'Rozario commented: "We want to address the heighted volatility in our share price over the past two days directly and unequivocally. I would like to personally affirm that there have been no material and fundamental changes to our core business, financial health, strategic priorities, or future outlook. Our strength lies in our people and the reputation we have ...
Market Declines Impact Several Companies
Financial Modeling Prep· 2025-10-09 22:00
Market Overview - The market has seen significant declines among several companies, including Vantage Corp, ZIVO Bioscience, CCSC Technology, Thunder Power Holdings, and GT Biopharma, influenced by company-specific developments and broader market conditions [1]. Vantage Corp - Vantage Corp's stock price plummeted by 81.09% to $1.21, with a trading volume of 15,522,991, far exceeding its average [2]. - The company is scheduled to present at the 2025 Gateway Conference, which may provide an opportunity to showcase its services and potentially influence future stock performance [2]. CCSC Technology International Holdings - CCSC Technology experienced a 41.45% decrease in its stock price to $1.3701, with a trading volume spike to 11,391,387 [3]. - The company announced a memorandum of understanding with Konstruktor Group to develop a new supply chain management center in Serbia, aiming to enhance its logistics and manufacturing infrastructure in Europe [3]. Thunder Power Holdings - Thunder Power Holdings saw a 35.07% fall in its stock price to $0.19, with minimal trading activity [4]. - The company is focused on expanding its operations in Taiwan and is making strides in the clean energy market, which may impact its future stock performance [4]. GT Biopharma - GT Biopharma's stock decreased by 33.23% to $0.72, with a trading volume of 5,837,946 [5]. - The company is advancing its TriKE® platform for cancer treatment and has reported its financial results for the second quarter of 2025, which may influence investor sentiment and future stock movements [5]. Conclusion - These developments highlight the dynamic nature of the market, with company-specific news and strategic initiatives playing a crucial role in stock performance [6]. Investors are closely monitoring these companies for any updates that could impact their future trajectories [6].
Vantage Corp to Present at the 2025 Gateway Conference on September 3, 2025 at 9:30 a.m. Pacific Time
Globenewswire· 2025-08-26 12:30
Company Overview - Vantage Corp is a shipbroking company providing comprehensive services including brokerage, consultancy, and operational support in the tanker market [1][3] - Founded in 2012 by five seasoned shipbrokers, Vantage Corp covers clean petroleum products, dirty petroleum products, biofuels, and vegetable oils [3] - The company operates through its 100%-owned subsidiary Vantage (BVI) Corporation and has a growing network of regional subsidiaries, including Vantage Shipbrokers Pte Ltd in Singapore and Vantage Nexus Commercial Brokers Co., L.L.C in the UAE [3] Upcoming Conference - Vantage Corp is scheduled to present at the 2025 Annual Gateway Conference on September 3 at 9:30 a.m. Pacific Time [2] - The presentation will be webcast live and available for replay, with executives available for one-on-one meetings throughout the conference [2] Gateway Conference Details - The Gateway Conference provides a platform for public and private companies to connect with investors, analysts, and partners [4] - Attendees will have access to presentations and one-on-one meetings with senior executives from over 75 companies across various sectors [5]